Company: CPMV
Filing Date: 2025-08-19
Form Type: 10-Q
Source: 0001683168-25-006318
Chunk: 0

Company: Mosaic ImmunoEngineering Inc.
Filing Date: 2025-08-19
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
Mosaic ImmunoEngineering, Inc.

Condensed Consolidated Balance Sheets

    June 30, 2025  
    December 31,  2024 

    unaudited  

    ASSETS 

    Current assets: 

    Cash and cash equivalents 
    $53,583  
    $115,019 
  
    Prepaid expenses and other current assets 
     4,116  
     26,592 
  
    Total current assets 
     57,699  
     141,611 
  
    Total assets 
    $57,699  
    $141,611 

    LIABILITIES AND STOCKHOLDERS’ DEFICIT 

    Current liabilities: 

    Accounts payable 
    $133,808  
    $134,865 
  
    Accrued compensation 
     4,011,998  
     3,767,652 
  
    Accrued consulting 
     787,903  
     787,903 
  
    Accrued expenses and other 
     636,632  
     646,850 
  
    Loan payable 
     200,000  
     200,000 
  
    Total current liabilities 
     5,770,341  
     5,537,270 

    Convertible notes, net 
     1,428,880  
     1,392,515 

    Total liabilities 
     7,199,221  
     6,929,785 

    Commitments and contingencies 
     –  
     – 

    Stockholders’ deficit: 

    Preferred stock, $0.00001 par value; 5,000,000 shares authorized: 
     –  
     – 
  
    Series A Convertible Voting Preferred Stock; 630,000 shares designated; no shares issued and outstanding 
     –  
     – 
  
    Series B Convertible Voting Preferred Stock; 70,000 shares designated; 70,000 shares issued and outstanding 
     1  
     1 
  
    Common stock, $0.00001 par value: 100,000,000 shares authorized: 7,242,137 shares issued and outstanding 
     72  
     72 
  
    Additional paid-in capital 
     2,050,073  
     2,050